Literature DB >> 7351001

Parity and prognosis in breast cancer.

A E Papatestas, M Mulvihill, C Josi, J Ioannovich, G Lesnick, A H Aufses.   

Abstract

Analysis of five-year disease-free survival rates in 608 women with operable breast cancer revealed that the reproductive history is a significant prognostic determinant. Overall parous women had a significantly higher cumulative five-year disease-free survival rate (60%), compared to the nulliparous (46%) (z = 2.5, p = 0.012). Significant differences were also noted when gravidity in addition to parity was taken as the determinant. The corresponding disease-free survival rates were 61% and 50%, respectively (z = 1.98, p = 0.048). Five-year survival rates were influenced in a similar manner by these variables but the observed differences were less significant. The trend toward higher survival rates in parous and gravidae women were noted in all tumor stages but achieved statistical significance only in stage III. The findings indicate that parity and gravidity affect not only the risk of breast cancer development but also the subsequent course of the disease. Parity seems to be a strong risk and prognostic factor than gravidity.

Entities:  

Mesh:

Year:  1980        PMID: 7351001     DOI: 10.1002/1097-0142(19800101)45:1<191::aid-cncr2820450130>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

Review 1.  Ethnic variation in breast cancer survival: a review.

Authors:  L Le Marchand
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

2.  Risk factors and 10-year breast cancer survival in northern Alberta.

Authors:  A W Lees; H J Jenkins; C L May; G Cherian; E W Lam; J Hanson
Journal:  Breast Cancer Res Treat       Date:  1989-03       Impact factor: 4.872

3.  Prognostic indicators in breast cancer.

Authors:  A E Papatestas; R Fagerstrom; W Gotsis
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-01

4.  Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis.

Authors:  S Warren Andersen; P A Newcomb; J M Hampton; L Titus-Ernstoff; K M Egan; A Trentham-Dietz
Journal:  Breast Cancer Res Treat       Date:  2011-07-19       Impact factor: 4.872

5.  Height, weight, and risk of breast cancer relapse.

Authors:  T Eberlein; R Simon; S Fisher; M E Lippman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

6.  Interrupted pregnancy as an indicator of poor prognosis in T1, 2, N0, M0 primary breast cancer.

Authors:  H E Ownby; S Martino; L D Roi; L Howard; J Russo; S Brooks; M J Brennan
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

7.  Parity is associated with axillary nodal involvement in operable breast cancer.

Authors:  R K Orr; K M Fraher
Journal:  Breast Cancer Res Treat       Date:  1995-04       Impact factor: 4.872

8.  Tumor subtype-specific associations of hormone-related reproductive factors on breast cancer survival.

Authors:  Nan Song; Ji-Yeob Choi; Hyuna Sung; Sujee Jeon; Seokang Chung; Minkyo Song; Sue K Park; Wonshik Han; Jong Won Lee; Mi Kyung Kim; Keun-Young Yoo; Sei-Hyun Ahn; Dong-Young Noh; Daehee Kang
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

9.  Body size and survival in premenopausal breast cancer.

Authors:  E R Greenberg; M P Vessey; K McPherson; R Doll; D Yeates
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

10.  Parity, age at first childbirth and the prognosis of primary breast cancer.

Authors:  N Kroman; J Wohlfahrt; K W Andersen; H T Mouridsen; T Westergaard; M Melbye
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.